BSE Live
Oct 17, 16:01Prev. Close
81.45
Open Price
81.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 17, 15:45Prev. Close
81.08
Open Price
80.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Bal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 15.92 | 15.80 | 15.69 | 14.82 | 14.82 | |
Total Share Capital | 15.92 | 15.80 | 15.69 | 14.82 | 14.82 | |
Reserves and Surplus | 82.90 | 89.78 | 78.95 | 71.56 | 63.56 | |
Total Reserves and Surplus | 82.90 | 89.78 | 78.95 | 71.56 | 63.56 | |
Total Shareholders Funds | 98.82 | 105.58 | 96.03 | 87.32 | 79.32 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 31.40 | 36.35 | 30.52 | 27.01 | 23.93 | |
Deferred Tax Liabilities [Net] | 0.00 | 3.94 | 2.86 | 2.47 | 4.40 | |
Other Long Term Liabilities | 1.28 | 1.34 | 1.23 | 3.63 | 3.04 | |
Long Term Provisions | 5.60 | 4.93 | 4.91 | 4.60 | 3.97 | |
Total Non-Current Liabilities | 38.28 | 46.56 | 39.52 | 37.72 | 35.35 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 113.21 | 97.48 | 94.71 | 70.99 | 75.05 | |
Trade Payables | 81.85 | 89.84 | 90.77 | 71.93 | 48.56 | |
Other Current Liabilities | 17.24 | 20.90 | 26.05 | 20.99 | 22.62 | |
Short Term Provisions | 1.16 | 0.93 | 0.63 | 0.67 | 0.65 | |
Total Current Liabilities | 213.46 | 209.16 | 212.15 | 164.57 | 146.87 | |
Total Capital And Liabilities | 350.56 | 361.30 | 347.70 | 289.61 | 261.54 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 70.95 | 53.18 | 52.62 | 44.92 | 45.42 | |
Intangible Assets | 15.82 | 11.38 | 10.45 | 7.98 | 7.23 | |
Capital Work-In-Progress | 2.79 | 0.47 | 0.00 | 1.16 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 89.56 | 65.03 | 63.07 | 54.06 | 52.65 | |
Non-Current Investments | 2.16 | 9.58 | 8.40 | 8.40 | 8.40 | |
Deferred Tax Assets [Net] | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.33 | |
Other Non-Current Assets | 10.80 | 5.55 | 6.29 | 6.89 | 6.96 | |
Total Non-Current Assets | 102.91 | 80.16 | 77.75 | 69.35 | 68.34 | |
CURRENT ASSETS | ||||||
Current Investments | 2.47 | 6.76 | 0.00 | 0.00 | 0.00 | |
Inventories | 102.78 | 87.49 | 97.69 | 73.97 | 60.12 | |
Trade Receivables | 94.85 | 103.10 | 94.84 | 77.91 | 69.44 | |
Cash And Cash Equivalents | 7.94 | 13.13 | 7.35 | 5.09 | 3.72 | |
Short Term Loans And Advances | 1.13 | 35.12 | 33.66 | 25.72 | 20.70 | |
OtherCurrentAssets | 38.49 | 35.54 | 36.41 | 37.57 | 39.23 | |
Total Current Assets | 247.65 | 281.14 | 269.95 | 220.27 | 193.20 | |
Total Assets | 350.56 | 361.30 | 347.70 | 289.61 | 261.54 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 17.10 | 16.96 | 16.44 | 16.25 | 4.34 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 58.88 | 0.07 | 68.25 | 74.94 | 56.77 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 6.26 | 5.22 | 3.32 | 1.63 | 1.85 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 165.18 | 194.97 | 202.03 | 183.60 | 150.43 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | 0.11 | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 2.16 | 9.59 | -- | -- | 9.57 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 2.47 | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
03.06.2025
Bal Pharma Consolidated March 2025 Net Sales at Rs 81.88 crore, down 13.47% Y-o-Y
04.03.2025
Bal Pharma Consolidated December 2024 Net Sales at Rs 73.15 crore, down 10.42% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
03.06.2025
Bal Pharma Consolidated March 2025 Net Sales at Rs 81.88 crore, down 13.47% Y-o-Y
04.03.2025
Bal Pharma Consolidated December 2024 Net Sales at Rs 73.15 crore, down 10.42% Y-o-Y